International Journal For Multidisciplinary Research

E-ISSN: 2582-2160     Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 3 May-June 2024 Submit your research before last 3 days of June to publish your research paper in the issue of May-June.

Rhythm Disorders in Pulmonary Arterial Hypertension (PAH) - What Therapeutic Options are Available?

Author(s) Z. BENNOUI
Country Algeria
Abstract Rhythm disorders in PAH are rare. In practice, they pose a therapeutic management challenge. Right ventricular dysfunction associated with hypoxia influences the prescription of antiarrhythmics; some of them are even contraindicated. We report three cases of idiopathic PAH complicated by atrial flutter (2 cases) and atrial fibrillation (1 case). The patients experienced right heart failure after a stabilization phase with specific vasodilators (bosentan, sildenafil, iloprost). They were treated with oral amiodarone, alongside treatment for right heart failure. Potassium levels were normal. Beta-blockers were not prescribed due to severe right ventricular dysfunction with arterial hypotension. Unfortunately, two patients developed hyperthyroidism secondary to amiodarone. Through these observations, we will discuss the different therapeutic options in these situations, referencing the literature.
Keywords Rhythm disorders, PAH, right ventricular dysfunction, arterial hypotension, hyperthyroidism, therapeutic options.
Field Medical / Pharmacy
Published In Volume 6, Issue 3, May-June 2024
Published On 2024-05-04
Cite This Rhythm Disorders in Pulmonary Arterial Hypertension (PAH) - What Therapeutic Options are Available? - Z. BENNOUI - IJFMR Volume 6, Issue 3, May-June 2024. DOI 10.36948/ijfmr.2024.v06i03.18999
DOI https://doi.org/10.36948/ijfmr.2024.v06i03.18999
Short DOI https://doi.org/gttbh8

Share this